The savings navigator
Ways to pay less for GLP-1 medications
The same drug can cost you $88 or $570 depending on how you buy it and what you qualify for. Here's every lever that actually lowers the bill in Canada — generic pricing, manufacturer programs, tax credits, and private-insurance rules — explained plainly.
1. Start with generic vs brand
For semaglutide, this is the biggest single decision. Since generics launched in May 2026, the identical molecule is available for a fraction of the brand price. This is the math most people never see.
| Option | Monthly (CAD) | The catch |
|---|---|---|
| Generic semaglutide (Costco) | $88–99 | You bring your own prescription |
| Generic via telehealth (all-in) | $149 | Consult + Rx + dispensing bundled |
| Brand Ozempic (retail) | $250–310 | Same molecule, brand markup |
| Brand Ozempic + Novo savings card | $90–250 | Card can narrow the gap toward generic |
See the full breakdown on generic semaglutide vs Ozempic.
2. You don't need a Costco membership to use the pharmacy
Costco Pharmacy is consistently the cheapest dispensing in Canada, and in most provinces a membership is not required to fill a prescription there — pharmacies are regulated separately from the warehouse. You can walk up to the pharmacy counter, hand over a valid prescription from your own doctor or a telehealth provider, and pay the (lower) dispensing price. Read the full Costco Pharmacy review.
3. Manufacturer & patient-support programs
Every brand has a program that can cut the cost — but eligibility varies, and some require private insurance. These are the real ones, with what each does. Always confirm current terms on the official manufacturer page before counting on them.
Novo Ozempic savings card
OzempicReduces the out-of-pocket cost of brand Ozempic, in some cases toward roughly generic pricing, with no pre-registration required.
Eligibility: Terms and eligibility vary and can change; typically aimed at patients with or without private coverage. Confirm current details on the official page.
Official program page →WegovyCare program
WegovyCan reduce the monthly cost of Wegovy to $149 for eligible patients.
Eligibility: Eligibility and terms vary and can change; often tied to coverage status. Confirm current details on the official program page.
Official program page →myMounjaro savings card
MounjaroCan reduce the monthly cost of Mounjaro to $185 for eligible patients.
Eligibility: Eligibility varies and can change. Confirm current terms on the official manufacturer page.
Official program page →LillyConnect copay card
ZepboundCan reduce the out-of-pocket copay for Zepbound to as little as $25 per month.
Eligibility: Requires private insurance; not available to uninsured or publicly insured patients. Terms vary and can change. Confirm on the official page.
Official program page →Novo Rybelsus patient support
RybelsusNovo Nordisk offers patient-support and savings resources for Rybelsus that may reduce out-of-pocket cost for some patients.
Eligibility: Availability and terms vary and can change. Confirm current details on the official manufacturer page.
Official program page →Novo Nordisk Care program
SaxendaProvides patient assistance that may help uninsured patients afford Saxenda.
Eligibility: Assistance is need- and eligibility-based and can change. Confirm current details on the official manufacturer page.
Official program page →4. The Medical Expense Tax Credit
Prescription medications that a doctor prescribes and a pharmacist dispenses — including GLP-1s — can generally count toward the federal Medical Expense Tax Credit (METC) when you file your taxes. The credit is non-refundable and only applies to eligible expenses above a threshold tied to your net income, so it won't make the drug free, but it can meaningfully reduce the real annual cost for people paying out of pocket. Keep your pharmacy receipts, and speak to a tax professional or check the Canada Revenue Agency's guidance for your specific situation — this is general information, not tax advice.
5. Private insurance: prior authorization & appeals
About 31% of employer private plans cover GLP-1s for weight loss; many more cover them for diabetes. If yours does, two things frequently stand between you and coverage:
Prior authorization. Many plans require your prescriber to submit a form documenting that you meet the plan's clinical criteria before they'll pay. Ask your prescriber's office to complete it, and ask your insurer exactly which criteria apply — a missing form is the most common reason a claim is denied.
Appeals. A first denial is not the end. Plans have an appeal process, and appeals often succeed when a prescriber adds clinical context — prior treatments tried, relevant conditions, or the medical rationale for this specific drug. Request the denial reason in writing, ask your prescriber for a letter of medical necessity, and submit within the plan's deadline.
This is educational information about how coverage processes generally work in Canada — not legal, medical, or insurance advice. Your plan's specific rules govern.